It has been reported that human embryonic stem cells (ESCs) derived from neural stem cells from DM1 patients display reduced proliferation and increased autophagy in a manner that is linked to the mammalian target of rapamycin (mTOR) signaling pathway. Here, MTOR is linked to myotonic dystrophy type 1.